Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2016-2026
2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (Above or equal to 65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)

3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 23-Valent Pneumococcal Polysaccharide Vaccine by Region
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Region
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer

11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region
11.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2021-2026)
11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

12 Key Players Analysis
12.1 MSD
12.1.1 MSD Company Information
12.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 MSD Main Business Overview
12.1.5 MSD Latest Developments
12.2 Sanofipasteur
12.2.1 Sanofipasteur Company Information
12.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofipasteur Main Business Overview
12.2.5 Sanofipasteur Latest Developments
12.3 CDIBP
12.3.1 CDIBP Company Information
12.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CDIBP Main Business Overview
12.3.5 CDIBP Latest Developments
...

13 Research Findings and Conclusion

List of Tables
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single Dose Vial
Table 3. Major Players of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2016-2021)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021) & (K Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 20. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) (K Dose)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 29. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 37. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 61. Key Application and Potential Industries of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 62. Key Challenges of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 63. Key Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 64. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026) & (K Dose)
Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Forecast by Region
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)
Table 71. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026) & (K Dose)
Table 73. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)
Table 75. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)
Table 77. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026) & (K Dose)
Table 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026) & (K Dose)
Table 83. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 86. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 88. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 89. MSD Main Business
Table 90. MSD Latest Developments
Table 91. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 93. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 94. Sanofipasteur Main Business
Table 95. Sanofipasteur Latest Developments
Table 96. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 98. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)
Table 99. CDIBP Main Business
Table 100. CDIBP Latest Developments
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2026 (K Dose)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2016-2021) & (K Dose)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2016-2021) & (K Dose)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (Above or equal to 65)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (Above or equal to 65) (2016-2021) & (K Dose)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2020
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2020
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 26. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 28. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 32. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 45. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 55. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 64. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs